NO980384L - Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler - Google Patents

Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler

Info

Publication number
NO980384L
NO980384L NO980384A NO980384A NO980384L NO 980384 L NO980384 L NO 980384L NO 980384 A NO980384 A NO 980384A NO 980384 A NO980384 A NO 980384A NO 980384 L NO980384 L NO 980384L
Authority
NO
Norway
Prior art keywords
preparation
low
dosage forms
solid dosage
dose drugs
Prior art date
Application number
NO980384A
Other languages
English (en)
Norwegian (no)
Other versions
NO980384D0 (no
Inventor
James Albert Napper
Karen Triona O'brien
Sultan James Manek
Rajinder Kumar
Julia Mary Loudon
Michael Sydney George Clark
Neil Mortimer
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO980384D0 publication Critical patent/NO980384D0/no
Publication of NO980384L publication Critical patent/NO980384L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO980384A 1995-07-29 1998-01-28 Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler NO980384L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
PCT/EP1996/003326 WO1997004750A2 (fr) 1995-07-29 1996-07-29 Procede de preparation de formes galeniques solides de medicaments en tres faibles doses

Publications (2)

Publication Number Publication Date
NO980384D0 NO980384D0 (no) 1998-01-28
NO980384L true NO980384L (no) 1998-03-26

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980384A NO980384L (no) 1995-07-29 1998-01-28 Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler

Country Status (25)

Country Link
EP (1) EP0841902A2 (fr)
JP (1) JPH11510493A (fr)
KR (1) KR19990035972A (fr)
CN (1) CN1196677A (fr)
AP (1) AP858A (fr)
AR (1) AR004178A1 (fr)
AU (1) AU716961B2 (fr)
BG (1) BG102266A (fr)
BR (1) BR9609804A (fr)
CA (1) CA2228048A1 (fr)
CZ (1) CZ24798A3 (fr)
DZ (1) DZ2077A1 (fr)
EA (2) EA199901055A1 (fr)
HU (1) HUP9900521A3 (fr)
IL (1) IL122897A0 (fr)
MA (1) MA23953A1 (fr)
MX (1) MX9800809A (fr)
NO (1) NO980384L (fr)
NZ (1) NZ315632A (fr)
OA (1) OA10659A (fr)
PL (1) PL325242A1 (fr)
SK (1) SK11098A3 (fr)
TR (1) TR199800156T1 (fr)
UY (1) UY24297A1 (fr)
WO (1) WO1997004750A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
NZ505807A (en) 1998-03-11 2003-01-31 Smithkline Beecham Corp Controlled release oral dosage form containing [R-(Z)]-alpha-(methoxyimino)-alpha-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride; useful for the treatment or prophylaxis of dementia
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
PT1591121E (pt) 2000-12-14 2009-07-20 Ortho Mcneil Janssen Pharm Processo para preparar produtos de hormona esteróide compreendendo um agente estabilizante na forma não cristalina
WO2005097076A2 (fr) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Produits pharmaceutiques a faibles doses
WO2026018154A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Associations de sabcoméline et d'antagonistes muscariniques ne pénétrant pas dans le snc
WO2026018155A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinaisons de sabcoméine avec des antagonistes muscariniques pénétrant dans le système nerveux non central à action prolongée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
EA199800179A1 (ru) 1998-10-29
AU6738496A (en) 1997-02-26
AR004178A1 (es) 1998-11-04
KR19990035972A (ko) 1999-05-25
CN1196677A (zh) 1998-10-21
WO1997004750A2 (fr) 1997-02-13
IL122897A0 (en) 1998-08-16
EP0841902A2 (fr) 1998-05-20
BG102266A (en) 1998-10-30
AP9801170A0 (en) 1998-01-31
WO1997004750A3 (fr) 1997-03-27
TR199800156T1 (xx) 1998-04-21
NZ315632A (en) 1999-11-29
CA2228048A1 (fr) 1997-02-13
DZ2077A1 (fr) 2002-07-22
EA000740B1 (ru) 2000-02-28
UY24297A1 (es) 1997-01-23
HUP9900521A3 (en) 2001-04-28
OA10659A (en) 2002-09-18
JPH11510493A (ja) 1999-09-14
NO980384D0 (no) 1998-01-28
SK11098A3 (en) 1998-07-08
CZ24798A3 (cs) 1998-06-17
PL325242A1 (en) 1998-07-06
EA199901055A1 (ru) 2000-06-26
HUP9900521A2 (hu) 1999-06-28
MX9800809A (es) 1998-04-30
AP858A (en) 2000-07-12
BR9609804A (pt) 1999-07-06
AU716961B2 (en) 2000-03-09
MA23953A1 (fr) 1997-04-01

Similar Documents

Publication Publication Date Title
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
IL117041A0 (en) Oral pharmaceutical dosage form
NO974557L (no) Fremgangsmåte for fremstilling av respirerbare partikler
DE69615887D1 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
FI973281L (fi) Menetelmä tiettyjen atsasykloheksapeptidien valmistamiseksi
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
EP0850057A4 (fr) Composes pharmaceutiques
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
MA23663A1 (fr) Procede de preparation de formulations pharmaceutiques
NO980384D0 (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
BR9607433A (pt) Composição farmacêutica para administração parental
NO913162D0 (no) Farmasoeytisk preparat for behandling av tonsillitt.
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
EP0932601A4 (fr) Procede de preparation de composes pharmaceutiques
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi
NO904470D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzodiazepinderivater.
IL149579A0 (en) Process for preparing solid dosage forms of low-dose drugs
AUPM590295A0 (en) Manufacture of pharmaceutical dosage forms
HK1010842A (en) Process for preparing solid dosage forms of very low-dose drugs
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO963174D0 (no) Fremgangsmåte for fremstilling av isovanillin